Benzinga | Aug 5, 2020 04:27PM EDT

Kindred Biosciences Q2 EPS $0.60 Up From $(0.37) YoY, Sales $39.57M May Not Compare To $10.54M Estimate

Kindred Biosciences (NASDAQ:KIN) reported quarterly earnings of $0.60 per share. This is a 262.16 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $39.57 million which beat the analyst consensus estimate of $10.54 million by 275.40 percent. This is a 3.10K percent increase over sales of $1.24 million the same period last year.